Hugo™ Robotic-Assisted Surgery for Gynecological Conditions
This study is evaluating the Medtronic Hugo™ Robotic Assisted Surgery (RAS) system for hysterectomy procedures. A hysterectomy is surgery to remove the uterus. This includes patients with conditions like uterine fibroids, menstrual disorders, adenomyosis, endometriosis, or uterine prolapse, and those being treated for cancer. The study aims to see how safe and effective the Hugo™ RAS system is during these surgeries. Researchers will measure the surgical success rate during the operation. This study plans to enroll up to 70 women, aged 22 and older, who are candidates for a hysterectomy using robotic-assisted surgery. The current recruitment status is unclear.
- Study design
- This is an interventional study with up to 70 participants. It is not specified if it is randomized or blinded.
- What's involved
- Participants will undergo a robotic-assisted hysterectomy using the Medtronic Hugo™ RAS system.
- Compensation
- Not stated in the trial record.
- Follow-up
- Surgical success is measured during the operation. Further follow-up is not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)
At a glance
Conditions
Where it's being run
5 sites across 4 statesStudy leadership
- Emma Rossi, MD · PRINCIPAL_INVESTIGATOR · Duke University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Surgical success rateIntraoperative
Surgical success rate is the procedure utilizing Hugo™ as outlined in the preoperatively defined surgical plan without conversion to an alternative robotic-assisted system, laparoscopy, or open surgery.